Simulations Plus (FRA:SD3) Valuation Rank


FRA:SD3 Simulations Plus Inc FRA:SD3
67 GF Score
Price €15.80
GF Value €32.93
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Simulations Plus Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Simulations Plus Valuation Rank Related Terms

FRA:SD3
67GF Score
Simulations Plus Inc FRA:SD3
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Simulations Plus (FRA:SD3) Overvalued in 2026?

Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued. The current stock price of €15.80 is trading 52% below its estimated GF Value™ of €32.93. GuruFocus considers Simulations Plus to be Significantly Undervalued.

Key valuation signals for FRA:SD3:

  • Valuation Rank:
  • GF Value™: €32.93 vs. price of €15.80 (52% below fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the FRA:SD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Simulations Plus Business Description

Other Exchanges SLP:USA
Address 800 Park Offices Drive, Suite 401, Research Triangle Park, Lancaster, NC, USA, 27709
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
67GF Score

Get the complete analysis for FRA:SD3

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.80
Price
€32.93
GF Value